Home600276 • SHA
add
Jiangsu Hengrui Pharmaceuticals Co Ltd
Previous close
¥42.35
Day range
¥41.22 - ¥42.34
Year range
¥35.51 - ¥50.50
Market cap
270.15B CNY
Avg Volume
28.76M
P/E ratio
62.96
Dividend yield
0.38%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 5.85B | 2.24% |
Operating expense | 3.57B | -2.71% |
Net income | 1.17B | 10.57% |
Net profit margin | 19.94 | 8.13% |
Earnings per share | — | — |
EBITDA | 1.52B | 27.62% |
Effective tax rate | 10.72% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.62B | -2.42% |
Total assets | 42.87B | 6.71% |
Total liabilities | 2.66B | -7.00% |
Total equity | 40.21B | — |
Shares outstanding | 6.12B | — |
Price to book | 6.55 | — |
Return on assets | 8.17% | — |
Return on capital | 8.69% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 1.17B | 10.57% |
Cash from operations | 1.43B | 6.81% |
Cash from investing | 239.38M | -91.20% |
Cash from financing | -468.13M | 70.63% |
Net change in cash | 1.20B | -52.41% |
Free cash flow | 129.56M | -69.20% |
About
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Founded
Apr 28, 1997
Website
Employees
19,611